戻る Agendas
ESSENTIAL BUSINESS CHANGE MANAGEMENT IN PHARMACOVIGILANCE: SYSTEMS, SERVICES AND SIMPLIFICATIONS
Session Chair(s)
Peter Richard Arlett, MD, FFPM, FRCP
Head Data Analytics and Methods Task Force
European Medicines Agency, Netherlands
ESSENTIAL BUSINESS CHANGE MANAGEMENT IN PHARMACOVIGILANCE: SYSTEMS, SERVICES AND SIMPLIFICATIONS
Speaker(s)
Scope and Benefits of Business Change in Pharmacovigilance
Peter Richard Arlett, MD, FFPM, FRCP
European Medicines Agency, Netherlands
Head Data Analytics and Methods Task Force
Impact of New Systems and Services on Innovative Industry Sector
Margaret Anne Walters
Merck, Sharp & Dohme Ltd, United Kingdom
Deputy EU Qualified Person for Pharmacovigilance
Impact of New Systems and Services on Generics Sector
Wendy Huisman, PHARMD
Avanzanite Bioscience, Netherlands
VP Quality and Patient Safety
Discussion on Impact on Industry
Elmar Kroth, DRSC
German Medicines Manufacturers' Association (BAH), Germany
Managing Director